Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
10-K
2023 FY
Annual report
15 Feb 24
8-K
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
15 Feb 24
8-K
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
8 Jan 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
8-K
Agios Reports Business Highlights and Third Quarter 2023 Financial Results
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
3 Aug 23
8-K
Departure of Directors or Certain Officers
14 Jun 23
S-8
Registration of securities for employees
13 Jun 23
8-K
Departure of Directors or Certain Officers
25 May 23
10-Q
2023 Q1
Quarterly report
4 May 23
8-K
Agios Reports Business Highlights and First Quarter 2023 Financial Results
4 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
8-K
Departure of Directors or Certain Officers
19 Apr 23
8-K
Amendments to Articles of Incorporation or Bylaws
3 Mar 23
S-8
Registration of securities for employees
23 Feb 23
S-3ASR
Automatic shelf registration
23 Feb 23
10-K
2022 FY
Annual report
23 Feb 23
8-K
Agios Reports Fourth Quarter and Full Year 2022 Financial Results
23 Feb 23
8-K
Regulation FD Disclosure
9 Jan 23
S-8
Registration of securities for employees
3 Jan 23
8-K
Departure of Directors or Certain Officers
16 Dec 22
8-K
Agios Appoints Tsveta Milanova as Chief Commercial Officer
6 Dec 22
10-Q
2022 Q3
Quarterly report
3 Nov 22
8-K
Agios Reports Business Highlights and Third Quarter 2022 Financial Results
3 Nov 22
8-K
Agios and Sagard Healthcare Partners Announce $131.8 Million Purchase Agreement for TIBSOVO® Royalty
27 Oct 22
8-K
Departure of Directors or Certain Officers
7 Oct 22
S-8
Registration of securities for employees
26 Sep 22
8-K
Agios Appoints Cecilia Jones as Chief Financial Officer
19 Sep 22
8-K
Departure of Directors or Certain Officers
7 Sep 22
8-K
Departure of Directors or Certain Officers
15 Aug 22
S-8
Registration of securities for employees
8 Aug 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
8-K
Agios Reports Business Highlights and Second Quarter 2022 Financial Results
4 Aug 22
8-K
Agios Appoints Brian Goff as Chief Executive Officer
12 Jul 22
Latest ownership filings
4
JACQUALYN A FOUSE
10 Apr 24
4
Kaye I Foster-Cheek
11 Mar 24
4
Kaye I Foster-Cheek
7 Mar 24
4
Theodore James Jr. Washburn
7 Mar 24
144
Notice of proposed sale of securities
7 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
4
Sarah Gheuens
5 Mar 24
4
Cecilia Jones
5 Mar 24
4
Theodore James Jr. Washburn
5 Mar 24
4
Brian Goff
5 Mar 24
4
James William Burns
5 Mar 24
4
Tsveta Milanova
5 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
4
David P Schenkein
29 Feb 24
144
Notice of proposed sale of securities
27 Feb 24
4
David P Schenkein
27 Feb 24
144
Notice of proposed sale of securities
26 Feb 24
4
Theodore James Jr. Washburn
22 Feb 24
4
Sarah Gheuens
14 Feb 24
4
James William Burns
14 Feb 24
4
Theodore James Jr. Washburn
14 Feb 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13G/A
Rock Springs Capital Management LP
14 Feb 24
SC 13G/A
BB BIOTECH AG
13 Feb 24
SC 13G/A
VANGUARD GROUP INC
12 Feb 24
SC 13G/A
VANGUARD GROUP INC
12 Feb 24
SC 13G/A
Farallon Capital Partners, L.P.
8 Feb 24
SC 13G/A
BlackRock Inc.
25 Jan 24
4
James William Burns
24 Jan 24
4
Sarah Gheuens
24 Jan 24
4
Cecilia Jones
24 Jan 24
4
JACQUALYN A FOUSE
24 Jan 24
4
Brian Goff
24 Jan 24
4
Tsveta Milanova
24 Jan 24
SC 13G/A
STATE STREET CORP
22 Jan 24
4
Brian Goff
9 Jan 24